Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Addex Therapeutics Ltd American Depositary Shares (ADXN)

https://www.addextherapeutics.com

Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/29/2020

Market Cap

12,311,453

Shares Outstanding

184,350,000

Weighted SO

1,119,782

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

IPHA --.--%

APM --.--%

CYAD --.--%

DYAI --.--%

ACGN --.--%

ERYP --.--%

SNGX --.--%

ATXI --.--%

KRON --.--%

Beta

1.9340

Last Div

0.0000

Range

5.0-27.9

Chg

-0.3000

Avg Vol

3375

Mkt Cap

12311453

Exch

NASDAQ

Country

CH

Phone

41 22 884 1555

DCF Diff

7.6603

DCF

-0.1103

Div Yield

0.0000

P/S

7.9278

EV Multiple

-1.0821

P/FV

-461.3187

Div Yield %

0.0000

P/E

-56.4677

PEG

-0.8117

Payout

0.0000

Current Ratio

0.7078

Quick Ratio

0.7078

Cash Ratio

0.3497

DSO

60.9829

DIO

0.0000

Op Cycle

60.9829

DPO

113.5840

CCC

-52.6011

Gross Margin

-2.8838

Op Margin

-6.4366

Pretax Margin

-6.5957

Net Margin

-8.3418

Eff Tax Rate

-0.3492

ROA

-3.3705

ROE

-4.5673

ROCE

6.5637

NI/EBT

1.2647

EBT/EBIT

1.0247

EBIT/Rev

-6.4366

Debt Ratio

0.0106

D/E

-0.0256

LT Debt/Cap

-0.0170

Total Debt/Cap

-0.0263

Int Coverage

-531.9600

CF/Debt

-222.4266

Equity Multi

-2.4239

Rec Turnover

5.9853

Pay Turnover

3.2135

Inv Turnover

0.0000

FA Turnover

41.6800

Asset Turnover

0.4040

OCF/Share

-0.0802

FCF/Share

-0.0803

Cash/Share

0.0167

OCF/Sales

-5.8101

FCF/OCF

1.0006

CF Coverage

-222.4266

ST Coverage

-639.4379

CapEx Coverage

-1789.6366

Div&CapEx Cov

-1789.6366

P/BV

-461.3187

P/B

-461.3187

P/S

7.9278

P/E

-56.4677

P/FCF

-1.3637

P/OCF

-81.0728

P/CF

-81.0728

PEG

-0.8117

P/S

7.9278

EV Multiple

-1.0821

P/FV

-461.3187

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 25, 05:00 Addex Shareholders Approve All Resolutions at Annual General Meeting GlobeNewswire Inc. Jun 18, 05:00 Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 GlobeNewswire Inc. Jun 05, 05:00 Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference GlobeNewswire Inc. Apr 17, 05:00 Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149 GlobeNewswire Inc. Nov 11, 06:00 Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024 GlobeNewswire Inc. Jul 22, 05:01 Addex’s Partner Discontinues ADX71149 development in Epilepsy - GlobeNewswire GlobeNewswire Inc. Jul 15, 05:00 Addex Presents Positive Results from GABAB PAM Cough - GlobeNewswire GlobeNewswire Inc. Jul 12, 05:01 Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) - GlobeNewswire GlobeNewswire Inc. Jul 01, 05:00 Addex Shareholders Approve All Resolutions at Annual General Meeting GlobeNewswire Inc. Jun 06, 05:00 Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update GlobeNewswire Inc. Jun 05, 05:00 Addex Convenes Annual General Meeting 2024 GlobeNewswire Inc. May 31, 05:00 Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024 GlobeNewswire Inc. Jan 09, 01:00 Addex to Present at the Swiss Equities Baader Conference GlobeNewswire Inc. Jan 09, 01:00 Addex to Present at the Swiss Equities Baader Conference GlobeNewswire Inc. Jan 09, 01:00 Addex to Present at the Swiss Equities Baader Conference GlobeNewswire Inc. Jan 05, 01:30 Addex to Present at Biotech Showcaseâ„¢ 2024 GlobeNewswire Inc. Jan 05, 01:30 Addex to Present at Biotech Showcaseâ„¢ 2024 GlobeNewswire Inc. Jan 05, 01:30 Addex to Present at Biotech Showcaseâ„¢ 2024 GlobeNewswire Inc. Jan 05, 01:30 Addex to Present at Biotech Showcaseâ„¢ 2024 GlobeNewswire Inc. Dec 20, 01:00 Addex Shareholders Approve All Resolutions at Extraordinary General Meeting

Revenue Product Segmentation